| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Glaucoma Center, University of California San Diego, La Jolla, California.
PURPOSE. To determine whether topical treatment of mouse eyes with latanoprost alters intraocular pressure (IOP).
METHODS. In a masked study design, NIH Swiss mice received a 2-µL topical instillation of 0.00015%, 0.0006%, 0.0025%, or 0.01% latanoprost or vehicle (phosphate-buffered saline [PBS]). After 1, 2, or 3 hours, the animals were anesthetized, and a fluid-filled glass microneedle connected to a pressure transducer was inserted through the cornea into the anterior chamber to measure IOP. The reduction of IOP after latanoprost measurement was calculated by the comparison between treated and nontreated eyes in the same mouse. The effect of latanoprost after a single 0.01% dose was also measured at 6, 12, and 24 hours. As in the previous study, the identity of all eye drop solutions was masked.
RESULTS. In mouse eyes receiving topical PBS, the mean IOP was 14.8 ± 2.2 mm Hg (n = 173 males). There was no significant difference in IOP between male and female eyes and between right and left eyes. At 1 hour after topical treatment with 0.00015% or 0.0025% latanoprost, IOP increased by as much as 11% ± 7%. At 2 and at 3 hours after application, IOP decreased in a dose-dependent manner. These decreases were significant in eyes receiving 0.0025% or 0.01% latanoprost (P < 0.05, Student-Newman-Keuls test) and the largest decrease (14% ± 8%) was noted 2 hours after treatment with 0.01% latanoprost. At 6, 12, or 24 hours after treatment, there was no difference in latanoprost- and PBS-treated eyes.
CONCLUSIONS. Latanoprost reduces mouse IOP in a dose-dependent manner. The mouse may be a useful model for studying the effect of drugs on IOP.
This article has been cited by other articles:
|
|
 |
|
  H. Murata, M. Aihara, Y.-N. Chen, T. Ota, J. Numaga, and M. Araie Imaging Mouse Retinal Ganglion Cells and Their Loss In Vivo by a Fundus Camera in the Normal and Ischemia-Reperfusion Model Invest. Ophthalmol. Vis. Sci., December 1, 2008; 49(12): 5546 - 5552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-K. Ju, K.-Y. Kim, J. D. Lindsey, M. Angert, K. X. Duong-Polk, R. T. Scott, J. J. Kim, I. Kukhmazov, M. H. Ellisman, G. A. Perkins, et al. Intraocular Pressure Elevation Induces Mitochondrial Fission and Triggers OPA1 Release in Glaucomatous Optic Nerve Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4903 - 4911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aihara, J. D. Lindsey, and R. N. Weinreb Effect on Diurnal Intraocular Pressure Variation of Eliminating the {alpha}-2 Adrenergic Receptor Subtypes in the Mouse Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 929 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Saleh, M. Nagaraju, and V. Porciatti Longitudinal Evaluation of Retinal Ganglion Cell Function and IOP in the DBA/2J Mouse Model of Glaucoma Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4564 - 4572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nagaraju, M. Saleh, and V. Porciatti IOP-Dependent Retinal Ganglion Cell Dysfunction in Glaucomatous DBA/2J Mice Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4573 - 4579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Crowston, C. A. Morris, J. D. Lindsey, and R. N. Weinreb Prostaglandin FP Receptors Do Not Contribute to 24-hour Intraocular Pressure Variation in Mice Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2095 - 2098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ota, M. Aihara, T. Saeki, S. Narumiya, and M. Araie The IOP-lowering effects and mechanism of action of tafluprost in prostanoid receptor-deficient mice Br. J. Ophthalmol., May 1, 2007; 91(5): 673 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Maeda, S. Tsujiya, T. Higashide, K. Toida, T. Todo, T. Ueyama, H. Okamura, and K. Sugiyama Circadian intraocular pressure rhythm is generated by clock genes. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 4050 - 4052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ota, M. Aihara, T. Saeki, S. Narumiya, and M. Araie The Effects of Prostaglandin Analogues on Prostanoid EP1, EP2, and EP3 Receptor-Deficient Mice. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3395 - 3399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Crowston, J. D. Lindsey, C. A. Morris, L. Wheeler, F. A. Medeiros, and R. N. Weinreb Effect of Bimatoprost on Intraocular Pressure in Prostaglandin FP Receptor Knockout Mice Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4571 - 4577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ota, M. Aihara, S. Narumiya, and M. Araie The Effects of Prostaglandin Analogues on IOP in Prostanoid FP-Receptor-Deficient Mice Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4159 - 4163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Y. Avila, A. Munera, A. Guzman, C. W. Do, Z. Wang, R. A. Stone, and M. M. Civan Noninvasive Intraocular Pressure Measurements in Mice by Pneumotonometry Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3274 - 3280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. M. John Mechanistic Insights into Glaucoma Provided by Experimental Genetics The Cogan Lecture Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2650 - 2661. [Full Text] [PDF]
|
|
|
|
|
|
T. Ota, H. Murata, E.-i. Sugimoto, M. Aihara, and M. Araie Prostaglandin Analogues and Mouse Intraocular Pressure: Effects of Tafluprost, Latanoprost, Travoprost, and Unoprostone, Considering 24-Hour Variation Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2006 - 2011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Mabuchi, M. Aihara, M. R. Mackey, J. D. Lindsey, and R. N. Weinreb Regional Optic Nerve Damage in Experimental Mouse Glaucoma Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4352 - 4358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Crowston, J. D. Lindsey, M. Aihara, and R. N. Weinreb Effect of Latanoprost on Intraocular Pressure in Mice Lacking the Prostaglandin FP Receptor Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3555 - 3559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Crowston, M. Aihara, J. D. Lindsey, and R. N. Weinreb Effect of Latanoprost on Outflow Facility in the Mouse Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2240 - 2245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Mabuchi, J. D. Lindsey, M. Aihara, M. R. Mackey, and R. N. Weinreb Optic Nerve Damage in Mice with a Targeted Type I Collagen Mutation Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1841 - 1845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Bernd, M. Aihara, J. D. Lindsey, and R. N. Weinreb Influence of Molecular Weight on Intracameral Dextran Movement to the Posterior Segment of the Mouse Eye Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 480 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aihara, J. D. Lindsey, and R. N. Weinreb Aqueous Humor Dynamics in Mice Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5168 - 5173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aihara, J. D. Lindsey, and R. N. Weinreb Experimental Mouse Ocular Hypertension: Establishment of the Model Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4314 - 4320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Mabuchi, M. Aihara, M. R. Mackey, J. D. Lindsey, and R. N. Weinreb Optic Nerve Damage in Experimental Mouse Ocular Hypertension Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4321 - 4330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aihara, J. D. Lindsey, and R. N. Weinreb Ocular Hypertension in Mice with a Targeted Type I Collagen Mutation Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1581 - 1585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Lindsey and R. N. Weinreb Identification of the Mouse Uveoscleral Outflow Pathway Using Fluorescent Dextran Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2201 - 2205. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
